↓ Skip to main content

Cochrane Database of Systematic Reviews

Ocrelizumab for multiple sclerosis

Overview of attention for article published in Cochrane database of systematic reviews, May 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
12 X users
facebook
3 Facebook pages
wikipedia
1 Wikipedia page

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
81 Mendeley
Title
Ocrelizumab for multiple sclerosis
Published in
Cochrane database of systematic reviews, May 2022
DOI 10.1002/14651858.cd013247.pub2
Pubmed ID
Authors

Mengbing Lin, Jian Zhang, Yueling Zhang, Jiefeng Luo, Shengliang Shi

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 81 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
Unknown 80 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 10%
Student > Bachelor 8 10%
Student > Ph. D. Student 7 9%
Other 6 7%
Student > Master 3 4%
Other 6 7%
Unknown 43 53%
Readers by discipline Count As %
Medicine and Dentistry 19 23%
Unspecified 2 2%
Biochemistry, Genetics and Molecular Biology 2 2%
Nursing and Health Professions 2 2%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Other 7 9%
Unknown 47 58%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 December 2023.
All research outputs
#1,642,588
of 25,967,142 outputs
Outputs from Cochrane database of systematic reviews
#3,360
of 13,170 outputs
Outputs of similar age
#36,922
of 448,334 outputs
Outputs of similar age from Cochrane database of systematic reviews
#51
of 118 outputs
Altmetric has tracked 25,967,142 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,170 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.2. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,334 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 118 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.